Global Naftopidil Market Growth 2025-2031
The global Naftopidil market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
United States market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Naftopidil players cover Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Naftopidil Industry Forecast” looks at past sales and reviews total world Naftopidil sales in 2024, providing a comprehensive analysis by region and market sector of projected Naftopidil sales for 2025 through 2031. With Naftopidil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Naftopidil industry.
This Insight Report provides a comprehensive analysis of the global Naftopidil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Naftopidil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Naftopidil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Naftopidil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Naftopidil.
This report presents a comprehensive overview, market shares, and growth opportunities of Naftopidil market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Naftopidil market?
What factors are driving Naftopidil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Naftopidil market opportunities vary by end market size?
How does Naftopidil break out by Type, by Application?
Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
United States market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Naftopidil players cover Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Naftopidil Industry Forecast” looks at past sales and reviews total world Naftopidil sales in 2024, providing a comprehensive analysis by region and market sector of projected Naftopidil sales for 2025 through 2031. With Naftopidil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Naftopidil industry.
This Insight Report provides a comprehensive analysis of the global Naftopidil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Naftopidil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Naftopidil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Naftopidil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Naftopidil.
This report presents a comprehensive overview, market shares, and growth opportunities of Naftopidil market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablet
- Capsule
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sinopharm Weiqida Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Aurobindo Pharma
- Erregierre
- Jeil Pharmaceutical
- Mylan Laboratories
- RA Chem Pharma
- Syn-Tech Chem & Pharm
- Procos
- Sagami Chemical Industry
- Daito Pharmaceutical
- Iwaki Seiyaku
- Hainan Simcere Pharmaceutical
What is the 10-year outlook for the global Naftopidil market?
What factors are driving Naftopidil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Naftopidil market opportunities vary by end market size?
How does Naftopidil break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Naftopidil Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Naftopidil by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Naftopidil by Country/Region, 2020, 2024 & 2031
2.2 Naftopidil Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Naftopidil Sales by Type
2.3.1 Global Naftopidil Sales Market Share by Type (2020-2025)
2.3.2 Global Naftopidil Revenue and Market Share by Type (2020-2025)
2.3.3 Global Naftopidil Sale Price by Type (2020-2025)
2.4 Naftopidil Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Naftopidil Sales by Application
2.5.1 Global Naftopidil Sale Market Share by Application (2020-2025)
2.5.2 Global Naftopidil Revenue and Market Share by Application (2020-2025)
2.5.3 Global Naftopidil Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Naftopidil Breakdown Data by Company
3.1.1 Global Naftopidil Annual Sales by Company (2020-2025)
3.1.2 Global Naftopidil Sales Market Share by Company (2020-2025)
3.2 Global Naftopidil Annual Revenue by Company (2020-2025)
3.2.1 Global Naftopidil Revenue by Company (2020-2025)
3.2.2 Global Naftopidil Revenue Market Share by Company (2020-2025)
3.3 Global Naftopidil Sale Price by Company
3.4 Key Manufacturers Naftopidil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Naftopidil Product Location Distribution
3.4.2 Players Naftopidil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NAFTOPIDIL BY GEOGRAPHIC REGION
4.1 World Historic Naftopidil Market Size by Geographic Region (2020-2025)
4.1.1 Global Naftopidil Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Naftopidil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Naftopidil Market Size by Country/Region (2020-2025)
4.2.1 Global Naftopidil Annual Sales by Country/Region (2020-2025)
4.2.2 Global Naftopidil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Naftopidil Sales Growth
4.4 APAC Naftopidil Sales Growth
4.5 Europe Naftopidil Sales Growth
4.6 Middle East & Africa Naftopidil Sales Growth
5 AMERICAS
5.1 Americas Naftopidil Sales by Country
5.1.1 Americas Naftopidil Sales by Country (2020-2025)
5.1.2 Americas Naftopidil Revenue by Country (2020-2025)
5.2 Americas Naftopidil Sales by Type (2020-2025)
5.3 Americas Naftopidil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Naftopidil Sales by Region
6.1.1 APAC Naftopidil Sales by Region (2020-2025)
6.1.2 APAC Naftopidil Revenue by Region (2020-2025)
6.2 APAC Naftopidil Sales by Type (2020-2025)
6.3 APAC Naftopidil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Naftopidil by Country
7.1.1 Europe Naftopidil Sales by Country (2020-2025)
7.1.2 Europe Naftopidil Revenue by Country (2020-2025)
7.2 Europe Naftopidil Sales by Type (2020-2025)
7.3 Europe Naftopidil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Naftopidil by Country
8.1.1 Middle East & Africa Naftopidil Sales by Country (2020-2025)
8.1.2 Middle East & Africa Naftopidil Revenue by Country (2020-2025)
8.2 Middle East & Africa Naftopidil Sales by Type (2020-2025)
8.3 Middle East & Africa Naftopidil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naftopidil
10.3 Manufacturing Process Analysis of Naftopidil
10.4 Industry Chain Structure of Naftopidil
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Naftopidil Distributors
11.3 Naftopidil Customer
12 WORLD FORECAST REVIEW FOR NAFTOPIDIL BY GEOGRAPHIC REGION
12.1 Global Naftopidil Market Size Forecast by Region
12.1.1 Global Naftopidil Forecast by Region (2026-2031)
12.1.2 Global Naftopidil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Naftopidil Forecast by Type (2026-2031)
12.7 Global Naftopidil Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sinopharm Weiqida Pharmaceutical
13.1.1 Sinopharm Weiqida Pharmaceutical Company Information
13.1.2 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolios and Specifications
13.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sinopharm Weiqida Pharmaceutical Main Business Overview
13.1.5 Sinopharm Weiqida Pharmaceutical Latest Developments
13.2 Shanghai Shyndec Pharmaceutical
13.2.1 Shanghai Shyndec Pharmaceutical Company Information
13.2.2 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolios and Specifications
13.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.2.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Naftopidil Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Erregierre
13.4.1 Erregierre Company Information
13.4.2 Erregierre Naftopidil Product Portfolios and Specifications
13.4.3 Erregierre Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Erregierre Main Business Overview
13.4.5 Erregierre Latest Developments
13.5 Jeil Pharmaceutical
13.5.1 Jeil Pharmaceutical Company Information
13.5.2 Jeil Pharmaceutical Naftopidil Product Portfolios and Specifications
13.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jeil Pharmaceutical Main Business Overview
13.5.5 Jeil Pharmaceutical Latest Developments
13.6 Mylan Laboratories
13.6.1 Mylan Laboratories Company Information
13.6.2 Mylan Laboratories Naftopidil Product Portfolios and Specifications
13.6.3 Mylan Laboratories Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mylan Laboratories Main Business Overview
13.6.5 Mylan Laboratories Latest Developments
13.7 RA Chem Pharma
13.7.1 RA Chem Pharma Company Information
13.7.2 RA Chem Pharma Naftopidil Product Portfolios and Specifications
13.7.3 RA Chem Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 RA Chem Pharma Main Business Overview
13.7.5 RA Chem Pharma Latest Developments
13.8 Syn-Tech Chem & Pharm
13.8.1 Syn-Tech Chem & Pharm Company Information
13.8.2 Syn-Tech Chem & Pharm Naftopidil Product Portfolios and Specifications
13.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Syn-Tech Chem & Pharm Main Business Overview
13.8.5 Syn-Tech Chem & Pharm Latest Developments
13.9 Procos
13.9.1 Procos Company Information
13.9.2 Procos Naftopidil Product Portfolios and Specifications
13.9.3 Procos Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Procos Main Business Overview
13.9.5 Procos Latest Developments
13.10 Sagami Chemical Industry
13.10.1 Sagami Chemical Industry Company Information
13.10.2 Sagami Chemical Industry Naftopidil Product Portfolios and Specifications
13.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sagami Chemical Industry Main Business Overview
13.10.5 Sagami Chemical Industry Latest Developments
13.11 Daito Pharmaceutical
13.11.1 Daito Pharmaceutical Company Information
13.11.2 Daito Pharmaceutical Naftopidil Product Portfolios and Specifications
13.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Daito Pharmaceutical Main Business Overview
13.11.5 Daito Pharmaceutical Latest Developments
13.12 Iwaki Seiyaku
13.12.1 Iwaki Seiyaku Company Information
13.12.2 Iwaki Seiyaku Naftopidil Product Portfolios and Specifications
13.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Iwaki Seiyaku Main Business Overview
13.12.5 Iwaki Seiyaku Latest Developments
13.13 Hainan Simcere Pharmaceutical
13.13.1 Hainan Simcere Pharmaceutical Company Information
13.13.2 Hainan Simcere Pharmaceutical Naftopidil Product Portfolios and Specifications
13.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hainan Simcere Pharmaceutical Main Business Overview
13.13.5 Hainan Simcere Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Naftopidil Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Naftopidil Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsule
Table 5. Global Naftopidil Sales byType (2020-2025) & (K Units)
Table 6. Global Naftopidil Sales Market Share byType (2020-2025)
Table 7. Global Naftopidil Revenue byType (2020-2025) & ($ million)
Table 8. Global Naftopidil Revenue Market Share byType (2020-2025)
Table 9. Global Naftopidil Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Naftopidil Sale by Application (2020-2025) & (K Units)
Table 11. Global Naftopidil Sale Market Share by Application (2020-2025)
Table 12. Global Naftopidil Revenue by Application (2020-2025) & ($ million)
Table 13. Global Naftopidil Revenue Market Share by Application (2020-2025)
Table 14. Global Naftopidil Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Naftopidil Sales by Company (2020-2025) & (K Units)
Table 16. Global Naftopidil Sales Market Share by Company (2020-2025)
Table 17. Global Naftopidil Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Naftopidil Revenue Market Share by Company (2020-2025)
Table 19. Global Naftopidil Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Naftopidil Producing Area Distribution and Sales Area
Table 21. Players Naftopidil Products Offered
Table 22. Naftopidil Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Naftopidil Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Naftopidil Sales Market Share Geographic Region (2020-2025)
Table 27. Global Naftopidil Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Naftopidil Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Naftopidil Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Naftopidil Sales Market Share by Country/Region (2020-2025)
Table 31. Global Naftopidil Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Naftopidil Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Naftopidil Sales by Country (2020-2025) & (K Units)
Table 34. Americas Naftopidil Sales Market Share by Country (2020-2025)
Table 35. Americas Naftopidil Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Naftopidil Sales byType (2020-2025) & (K Units)
Table 37. Americas Naftopidil Sales by Application (2020-2025) & (K Units)
Table 38. APAC Naftopidil Sales by Region (2020-2025) & (K Units)
Table 39. APAC Naftopidil Sales Market Share by Region (2020-2025)
Table 40. APAC Naftopidil Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Naftopidil Sales byType (2020-2025) & (K Units)
Table 42. APAC Naftopidil Sales by Application (2020-2025) & (K Units)
Table 43. Europe Naftopidil Sales by Country (2020-2025) & (K Units)
Table 44. Europe Naftopidil Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Naftopidil Sales byType (2020-2025) & (K Units)
Table 46. Europe Naftopidil Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Naftopidil Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Naftopidil Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Naftopidil Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Naftopidil Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Naftopidil
Table 52. Key Market Challenges & Risks of Naftopidil
Table 53. Key IndustryTrends of Naftopidil
Table 54. Naftopidil Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Naftopidil Distributors List
Table 57. Naftopidil Customer List
Table 58. Global Naftopidil SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Naftopidil RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Naftopidil Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Naftopidil SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Naftopidil Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Naftopidil RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Naftopidil RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Naftopidil SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Naftopidil RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Naftopidil SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Naftopidil RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sinopharm Weiqida Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 73. Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 74. Sinopharm Weiqida Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sinopharm Weiqida Pharmaceutical Main Business
Table 76. Sinopharm Weiqida Pharmaceutical Latest Developments
Table 77. Shanghai Shyndec Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 78. Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 79. Shanghai Shyndec Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Shanghai Shyndec Pharmaceutical Main Business
Table 81. Shanghai Shyndec Pharmaceutical Latest Developments
Table 82. Aurobindo Pharma Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 83. Aurobindo Pharma Naftopidil Product Portfolios and Specifications
Table 84. Aurobindo Pharma Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Aurobindo Pharma Main Business
Table 86. Aurobindo Pharma Latest Developments
Table 87. Erregierre Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 88. Erregierre Naftopidil Product Portfolios and Specifications
Table 89. Erregierre Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Erregierre Main Business
Table 91. Erregierre Latest Developments
Table 92. Jeil Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 93. Jeil Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 94. Jeil Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Jeil Pharmaceutical Main Business
Table 96. Jeil Pharmaceutical Latest Developments
Table 97. Mylan Laboratories Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Laboratories Naftopidil Product Portfolios and Specifications
Table 99. Mylan Laboratories Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Mylan Laboratories Main Business
Table 101. Mylan Laboratories Latest Developments
Table 102. RA Chem Pharma Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 103. RA Chem Pharma Naftopidil Product Portfolios and Specifications
Table 104. RA Chem Pharma Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. RA Chem Pharma Main Business
Table 106. RA Chem Pharma Latest Developments
Table 107. Syn-Tech Chem & Pharm Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 108. Syn-Tech Chem & Pharm Naftopidil Product Portfolios and Specifications
Table 109. Syn-Tech Chem & Pharm Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Syn-Tech Chem & Pharm Main Business
Table 111. Syn-Tech Chem & Pharm Latest Developments
Table 112. Procos Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 113. Procos Naftopidil Product Portfolios and Specifications
Table 114. Procos Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Procos Main Business
Table 116. Procos Latest Developments
Table 117. Sagami Chemical Industry Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 118. Sagami Chemical Industry Naftopidil Product Portfolios and Specifications
Table 119. Sagami Chemical Industry Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Sagami Chemical Industry Main Business
Table 121. Sagami Chemical Industry Latest Developments
Table 122. Daito Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 123. Daito Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 124. Daito Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Daito Pharmaceutical Main Business
Table 126. Daito Pharmaceutical Latest Developments
Table 127. Iwaki Seiyaku Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 128. Iwaki Seiyaku Naftopidil Product Portfolios and Specifications
Table 129. Iwaki Seiyaku Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Iwaki Seiyaku Main Business
Table 131. Iwaki Seiyaku Latest Developments
Table 132. Hainan Simcere Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 133. Hainan Simcere Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 134. Hainan Simcere Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Hainan Simcere Pharmaceutical Main Business
Table 136. Hainan Simcere Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Naftopidil
Figure 2. Naftopidil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naftopidil Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Naftopidil Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Naftopidil Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Naftopidil Sales Market Share by Country/Region (2024)
Figure 10. Naftopidil Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsule
Figure 13. Global Naftopidil Sales Market Share byType in 2025
Figure 14. Global Naftopidil Revenue Market Share byType (2020-2025)
Figure 15. Naftopidil Consumed in Hospital
Figure 16. Global Naftopidil Market: Hospital (2020-2025) & (K Units)
Figure 17. Naftopidil Consumed in Clinic
Figure 18. Global Naftopidil Market: Clinic (2020-2025) & (K Units)
Figure 19. Global Naftopidil Sale Market Share by Application (2024)
Figure 20. Global Naftopidil Revenue Market Share by Application in 2025
Figure 21. Naftopidil Sales by Company in 2025 (K Units)
Figure 22. Global Naftopidil Sales Market Share by Company in 2025
Figure 23. Naftopidil Revenue by Company in 2025 ($ millions)
Figure 24. Global Naftopidil Revenue Market Share by Company in 2025
Figure 25. Global Naftopidil Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Naftopidil Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Naftopidil Sales 2020-2025 (K Units)
Figure 28. Americas Naftopidil Revenue 2020-2025 ($ millions)
Figure 29. APAC Naftopidil Sales 2020-2025 (K Units)
Figure 30. APAC Naftopidil Revenue 2020-2025 ($ millions)
Figure 31. Europe Naftopidil Sales 2020-2025 (K Units)
Figure 32. Europe Naftopidil Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Naftopidil Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Naftopidil Revenue 2020-2025 ($ millions)
Figure 35. Americas Naftopidil Sales Market Share by Country in 2025
Figure 36. Americas Naftopidil Revenue Market Share by Country (2020-2025)
Figure 37. Americas Naftopidil Sales Market Share byType (2020-2025)
Figure 38. Americas Naftopidil Sales Market Share by Application (2020-2025)
Figure 39. United States Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Naftopidil Sales Market Share by Region in 2025
Figure 44. APAC Naftopidil Revenue Market Share by Region (2020-2025)
Figure 45. APAC Naftopidil Sales Market Share byType (2020-2025)
Figure 46. APAC Naftopidil Sales Market Share by Application (2020-2025)
Figure 47. China Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 51. India Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Naftopidil Sales Market Share by Country in 2025
Figure 55. Europe Naftopidil Revenue Market Share by Country (2020-2025)
Figure 56. Europe Naftopidil Sales Market Share byType (2020-2025)
Figure 57. Europe Naftopidil Sales Market Share by Application (2020-2025)
Figure 58. Germany Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 59.France Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Naftopidil Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Naftopidil Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Naftopidil Sales Market Share by Application (2020-2025)
Figure 66. Egypt Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Naftopidil in 2025
Figure 72. Manufacturing Process Analysis of Naftopidil
Figure 73. Industry Chain Structure of Naftopidil
Figure 74. Channels of Distribution
Figure 75. Global Naftopidil Sales MarketForecast by Region (2026-2031)
Figure 76. Global Naftopidil Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Naftopidil Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Naftopidil Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Naftopidil Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Naftopidil Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Naftopidil Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Naftopidil by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Naftopidil by Country/Region, 2020, 2024 & 2031
2.2 Naftopidil Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Naftopidil Sales by Type
2.3.1 Global Naftopidil Sales Market Share by Type (2020-2025)
2.3.2 Global Naftopidil Revenue and Market Share by Type (2020-2025)
2.3.3 Global Naftopidil Sale Price by Type (2020-2025)
2.4 Naftopidil Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Naftopidil Sales by Application
2.5.1 Global Naftopidil Sale Market Share by Application (2020-2025)
2.5.2 Global Naftopidil Revenue and Market Share by Application (2020-2025)
2.5.3 Global Naftopidil Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Naftopidil Breakdown Data by Company
3.1.1 Global Naftopidil Annual Sales by Company (2020-2025)
3.1.2 Global Naftopidil Sales Market Share by Company (2020-2025)
3.2 Global Naftopidil Annual Revenue by Company (2020-2025)
3.2.1 Global Naftopidil Revenue by Company (2020-2025)
3.2.2 Global Naftopidil Revenue Market Share by Company (2020-2025)
3.3 Global Naftopidil Sale Price by Company
3.4 Key Manufacturers Naftopidil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Naftopidil Product Location Distribution
3.4.2 Players Naftopidil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NAFTOPIDIL BY GEOGRAPHIC REGION
4.1 World Historic Naftopidil Market Size by Geographic Region (2020-2025)
4.1.1 Global Naftopidil Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Naftopidil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Naftopidil Market Size by Country/Region (2020-2025)
4.2.1 Global Naftopidil Annual Sales by Country/Region (2020-2025)
4.2.2 Global Naftopidil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Naftopidil Sales Growth
4.4 APAC Naftopidil Sales Growth
4.5 Europe Naftopidil Sales Growth
4.6 Middle East & Africa Naftopidil Sales Growth
5 AMERICAS
5.1 Americas Naftopidil Sales by Country
5.1.1 Americas Naftopidil Sales by Country (2020-2025)
5.1.2 Americas Naftopidil Revenue by Country (2020-2025)
5.2 Americas Naftopidil Sales by Type (2020-2025)
5.3 Americas Naftopidil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Naftopidil Sales by Region
6.1.1 APAC Naftopidil Sales by Region (2020-2025)
6.1.2 APAC Naftopidil Revenue by Region (2020-2025)
6.2 APAC Naftopidil Sales by Type (2020-2025)
6.3 APAC Naftopidil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Naftopidil by Country
7.1.1 Europe Naftopidil Sales by Country (2020-2025)
7.1.2 Europe Naftopidil Revenue by Country (2020-2025)
7.2 Europe Naftopidil Sales by Type (2020-2025)
7.3 Europe Naftopidil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Naftopidil by Country
8.1.1 Middle East & Africa Naftopidil Sales by Country (2020-2025)
8.1.2 Middle East & Africa Naftopidil Revenue by Country (2020-2025)
8.2 Middle East & Africa Naftopidil Sales by Type (2020-2025)
8.3 Middle East & Africa Naftopidil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naftopidil
10.3 Manufacturing Process Analysis of Naftopidil
10.4 Industry Chain Structure of Naftopidil
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Naftopidil Distributors
11.3 Naftopidil Customer
12 WORLD FORECAST REVIEW FOR NAFTOPIDIL BY GEOGRAPHIC REGION
12.1 Global Naftopidil Market Size Forecast by Region
12.1.1 Global Naftopidil Forecast by Region (2026-2031)
12.1.2 Global Naftopidil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Naftopidil Forecast by Type (2026-2031)
12.7 Global Naftopidil Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sinopharm Weiqida Pharmaceutical
13.1.1 Sinopharm Weiqida Pharmaceutical Company Information
13.1.2 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolios and Specifications
13.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sinopharm Weiqida Pharmaceutical Main Business Overview
13.1.5 Sinopharm Weiqida Pharmaceutical Latest Developments
13.2 Shanghai Shyndec Pharmaceutical
13.2.1 Shanghai Shyndec Pharmaceutical Company Information
13.2.2 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolios and Specifications
13.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.2.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Naftopidil Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Erregierre
13.4.1 Erregierre Company Information
13.4.2 Erregierre Naftopidil Product Portfolios and Specifications
13.4.3 Erregierre Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Erregierre Main Business Overview
13.4.5 Erregierre Latest Developments
13.5 Jeil Pharmaceutical
13.5.1 Jeil Pharmaceutical Company Information
13.5.2 Jeil Pharmaceutical Naftopidil Product Portfolios and Specifications
13.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jeil Pharmaceutical Main Business Overview
13.5.5 Jeil Pharmaceutical Latest Developments
13.6 Mylan Laboratories
13.6.1 Mylan Laboratories Company Information
13.6.2 Mylan Laboratories Naftopidil Product Portfolios and Specifications
13.6.3 Mylan Laboratories Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mylan Laboratories Main Business Overview
13.6.5 Mylan Laboratories Latest Developments
13.7 RA Chem Pharma
13.7.1 RA Chem Pharma Company Information
13.7.2 RA Chem Pharma Naftopidil Product Portfolios and Specifications
13.7.3 RA Chem Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 RA Chem Pharma Main Business Overview
13.7.5 RA Chem Pharma Latest Developments
13.8 Syn-Tech Chem & Pharm
13.8.1 Syn-Tech Chem & Pharm Company Information
13.8.2 Syn-Tech Chem & Pharm Naftopidil Product Portfolios and Specifications
13.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Syn-Tech Chem & Pharm Main Business Overview
13.8.5 Syn-Tech Chem & Pharm Latest Developments
13.9 Procos
13.9.1 Procos Company Information
13.9.2 Procos Naftopidil Product Portfolios and Specifications
13.9.3 Procos Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Procos Main Business Overview
13.9.5 Procos Latest Developments
13.10 Sagami Chemical Industry
13.10.1 Sagami Chemical Industry Company Information
13.10.2 Sagami Chemical Industry Naftopidil Product Portfolios and Specifications
13.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sagami Chemical Industry Main Business Overview
13.10.5 Sagami Chemical Industry Latest Developments
13.11 Daito Pharmaceutical
13.11.1 Daito Pharmaceutical Company Information
13.11.2 Daito Pharmaceutical Naftopidil Product Portfolios and Specifications
13.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Daito Pharmaceutical Main Business Overview
13.11.5 Daito Pharmaceutical Latest Developments
13.12 Iwaki Seiyaku
13.12.1 Iwaki Seiyaku Company Information
13.12.2 Iwaki Seiyaku Naftopidil Product Portfolios and Specifications
13.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Iwaki Seiyaku Main Business Overview
13.12.5 Iwaki Seiyaku Latest Developments
13.13 Hainan Simcere Pharmaceutical
13.13.1 Hainan Simcere Pharmaceutical Company Information
13.13.2 Hainan Simcere Pharmaceutical Naftopidil Product Portfolios and Specifications
13.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hainan Simcere Pharmaceutical Main Business Overview
13.13.5 Hainan Simcere Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Naftopidil Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Naftopidil Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsule
Table 5. Global Naftopidil Sales byType (2020-2025) & (K Units)
Table 6. Global Naftopidil Sales Market Share byType (2020-2025)
Table 7. Global Naftopidil Revenue byType (2020-2025) & ($ million)
Table 8. Global Naftopidil Revenue Market Share byType (2020-2025)
Table 9. Global Naftopidil Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Naftopidil Sale by Application (2020-2025) & (K Units)
Table 11. Global Naftopidil Sale Market Share by Application (2020-2025)
Table 12. Global Naftopidil Revenue by Application (2020-2025) & ($ million)
Table 13. Global Naftopidil Revenue Market Share by Application (2020-2025)
Table 14. Global Naftopidil Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Naftopidil Sales by Company (2020-2025) & (K Units)
Table 16. Global Naftopidil Sales Market Share by Company (2020-2025)
Table 17. Global Naftopidil Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Naftopidil Revenue Market Share by Company (2020-2025)
Table 19. Global Naftopidil Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Naftopidil Producing Area Distribution and Sales Area
Table 21. Players Naftopidil Products Offered
Table 22. Naftopidil Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Naftopidil Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Naftopidil Sales Market Share Geographic Region (2020-2025)
Table 27. Global Naftopidil Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Naftopidil Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Naftopidil Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Naftopidil Sales Market Share by Country/Region (2020-2025)
Table 31. Global Naftopidil Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Naftopidil Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Naftopidil Sales by Country (2020-2025) & (K Units)
Table 34. Americas Naftopidil Sales Market Share by Country (2020-2025)
Table 35. Americas Naftopidil Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Naftopidil Sales byType (2020-2025) & (K Units)
Table 37. Americas Naftopidil Sales by Application (2020-2025) & (K Units)
Table 38. APAC Naftopidil Sales by Region (2020-2025) & (K Units)
Table 39. APAC Naftopidil Sales Market Share by Region (2020-2025)
Table 40. APAC Naftopidil Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Naftopidil Sales byType (2020-2025) & (K Units)
Table 42. APAC Naftopidil Sales by Application (2020-2025) & (K Units)
Table 43. Europe Naftopidil Sales by Country (2020-2025) & (K Units)
Table 44. Europe Naftopidil Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Naftopidil Sales byType (2020-2025) & (K Units)
Table 46. Europe Naftopidil Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Naftopidil Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Naftopidil Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Naftopidil Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Naftopidil Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Naftopidil
Table 52. Key Market Challenges & Risks of Naftopidil
Table 53. Key IndustryTrends of Naftopidil
Table 54. Naftopidil Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Naftopidil Distributors List
Table 57. Naftopidil Customer List
Table 58. Global Naftopidil SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Naftopidil RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Naftopidil Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Naftopidil SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Naftopidil Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Naftopidil RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Naftopidil SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Naftopidil RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Naftopidil SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Naftopidil RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Naftopidil SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Naftopidil RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sinopharm Weiqida Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 73. Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 74. Sinopharm Weiqida Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sinopharm Weiqida Pharmaceutical Main Business
Table 76. Sinopharm Weiqida Pharmaceutical Latest Developments
Table 77. Shanghai Shyndec Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 78. Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 79. Shanghai Shyndec Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Shanghai Shyndec Pharmaceutical Main Business
Table 81. Shanghai Shyndec Pharmaceutical Latest Developments
Table 82. Aurobindo Pharma Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 83. Aurobindo Pharma Naftopidil Product Portfolios and Specifications
Table 84. Aurobindo Pharma Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Aurobindo Pharma Main Business
Table 86. Aurobindo Pharma Latest Developments
Table 87. Erregierre Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 88. Erregierre Naftopidil Product Portfolios and Specifications
Table 89. Erregierre Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Erregierre Main Business
Table 91. Erregierre Latest Developments
Table 92. Jeil Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 93. Jeil Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 94. Jeil Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Jeil Pharmaceutical Main Business
Table 96. Jeil Pharmaceutical Latest Developments
Table 97. Mylan Laboratories Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Laboratories Naftopidil Product Portfolios and Specifications
Table 99. Mylan Laboratories Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Mylan Laboratories Main Business
Table 101. Mylan Laboratories Latest Developments
Table 102. RA Chem Pharma Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 103. RA Chem Pharma Naftopidil Product Portfolios and Specifications
Table 104. RA Chem Pharma Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. RA Chem Pharma Main Business
Table 106. RA Chem Pharma Latest Developments
Table 107. Syn-Tech Chem & Pharm Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 108. Syn-Tech Chem & Pharm Naftopidil Product Portfolios and Specifications
Table 109. Syn-Tech Chem & Pharm Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Syn-Tech Chem & Pharm Main Business
Table 111. Syn-Tech Chem & Pharm Latest Developments
Table 112. Procos Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 113. Procos Naftopidil Product Portfolios and Specifications
Table 114. Procos Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Procos Main Business
Table 116. Procos Latest Developments
Table 117. Sagami Chemical Industry Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 118. Sagami Chemical Industry Naftopidil Product Portfolios and Specifications
Table 119. Sagami Chemical Industry Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Sagami Chemical Industry Main Business
Table 121. Sagami Chemical Industry Latest Developments
Table 122. Daito Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 123. Daito Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 124. Daito Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Daito Pharmaceutical Main Business
Table 126. Daito Pharmaceutical Latest Developments
Table 127. Iwaki Seiyaku Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 128. Iwaki Seiyaku Naftopidil Product Portfolios and Specifications
Table 129. Iwaki Seiyaku Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Iwaki Seiyaku Main Business
Table 131. Iwaki Seiyaku Latest Developments
Table 132. Hainan Simcere Pharmaceutical Basic Information, Naftopidil Manufacturing Base, Sales Area and Its Competitors
Table 133. Hainan Simcere Pharmaceutical Naftopidil Product Portfolios and Specifications
Table 134. Hainan Simcere Pharmaceutical Naftopidil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Hainan Simcere Pharmaceutical Main Business
Table 136. Hainan Simcere Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Naftopidil
Figure 2. Naftopidil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naftopidil Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Naftopidil Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Naftopidil Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Naftopidil Sales Market Share by Country/Region (2024)
Figure 10. Naftopidil Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsule
Figure 13. Global Naftopidil Sales Market Share byType in 2025
Figure 14. Global Naftopidil Revenue Market Share byType (2020-2025)
Figure 15. Naftopidil Consumed in Hospital
Figure 16. Global Naftopidil Market: Hospital (2020-2025) & (K Units)
Figure 17. Naftopidil Consumed in Clinic
Figure 18. Global Naftopidil Market: Clinic (2020-2025) & (K Units)
Figure 19. Global Naftopidil Sale Market Share by Application (2024)
Figure 20. Global Naftopidil Revenue Market Share by Application in 2025
Figure 21. Naftopidil Sales by Company in 2025 (K Units)
Figure 22. Global Naftopidil Sales Market Share by Company in 2025
Figure 23. Naftopidil Revenue by Company in 2025 ($ millions)
Figure 24. Global Naftopidil Revenue Market Share by Company in 2025
Figure 25. Global Naftopidil Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Naftopidil Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Naftopidil Sales 2020-2025 (K Units)
Figure 28. Americas Naftopidil Revenue 2020-2025 ($ millions)
Figure 29. APAC Naftopidil Sales 2020-2025 (K Units)
Figure 30. APAC Naftopidil Revenue 2020-2025 ($ millions)
Figure 31. Europe Naftopidil Sales 2020-2025 (K Units)
Figure 32. Europe Naftopidil Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Naftopidil Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Naftopidil Revenue 2020-2025 ($ millions)
Figure 35. Americas Naftopidil Sales Market Share by Country in 2025
Figure 36. Americas Naftopidil Revenue Market Share by Country (2020-2025)
Figure 37. Americas Naftopidil Sales Market Share byType (2020-2025)
Figure 38. Americas Naftopidil Sales Market Share by Application (2020-2025)
Figure 39. United States Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Naftopidil Sales Market Share by Region in 2025
Figure 44. APAC Naftopidil Revenue Market Share by Region (2020-2025)
Figure 45. APAC Naftopidil Sales Market Share byType (2020-2025)
Figure 46. APAC Naftopidil Sales Market Share by Application (2020-2025)
Figure 47. China Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 51. India Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Naftopidil Sales Market Share by Country in 2025
Figure 55. Europe Naftopidil Revenue Market Share by Country (2020-2025)
Figure 56. Europe Naftopidil Sales Market Share byType (2020-2025)
Figure 57. Europe Naftopidil Sales Market Share by Application (2020-2025)
Figure 58. Germany Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 59.France Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Naftopidil Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Naftopidil Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Naftopidil Sales Market Share by Application (2020-2025)
Figure 66. Egypt Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Naftopidil Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Naftopidil in 2025
Figure 72. Manufacturing Process Analysis of Naftopidil
Figure 73. Industry Chain Structure of Naftopidil
Figure 74. Channels of Distribution
Figure 75. Global Naftopidil Sales MarketForecast by Region (2026-2031)
Figure 76. Global Naftopidil Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Naftopidil Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Naftopidil Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Naftopidil Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Naftopidil Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Postmenopausal Osteoporosis Therapeutics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
87 pages
Global Geriatric Medicine Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
107 pages
Global Meniscal Repair System Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
87 pages
Global Special Coagulation Test Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
109 pages
Global Orthopedics Plates and Screws Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
104 pages
